|
|
Security Type
|
Security
Class Title |
Fee
Calculation or Carry Forward Rule |
Amount
Registered(1) |
Proposed
Maximum Offering Price Per Unit |
Maximum
Aggregate Offering Price |
Fee Rate
|
Amount of
Registration Fee |
Carry
Forward
Form
Type
|
Carry
Forward
File
Number
|
Carry
Forward
Initial
Effective
date
|
Filing Fee
Previously
Paid In
Connection
with Unsold
Securities to
be Carried
Forward
|
|
Newly Registered Securities
|
||||||||||||
|
Fees to Be Paid
|
Equity
|
Common stock, par value $0.0001 per share
|
457(c)
|
6,250,000(2)
|
$1.49(3)
|
$9,312,500
|
0.00013810
|
$1,286.06
|
||||
|
Fees
Previously
Paid
|
N/A
|
N/A
|
N/A
|
N/A
|
N/A
|
N/A
|
N/A
|
N/A
|
||||
|
Carry Forward Securities
|
||||||||||||
|
Carry Forward Securities
|
N/A
|
N/A
|
N/A
|
N/A
|
N/A
|
N/A
|
N/A
|
N/A
|
||||
|
Total Offering Amount
|
$9,312,500
|
$1,286.06
|
||||||||||
|
Total Fees Previously Paid
|
—
|
|||||||||||
|
Total Fee Offsets
|
—
|
|||||||||||
|
Net Fee Due
|
$1,286.06
|
|||||||||||
| (1) |
Represents the shares of common stock, par value $0.0001 per share (the “common stock”), of Prelude Therapeutics Incorporated (the “Registrant”) that will be offered for resale by the selling stockholder pursuant to the prospectus to which
this exhibit is attached. Pursuant to Rule 416 under the Securities Act of 1933, as amended (the “Securities Act”), the shares being registered hereunder include such indeterminate number of additional shares of common stock as may be
issuable as a result of stock splits, stock dividends or similar transactions with respect to the shares being registered hereunder.
|
| (2) |
Consists of an aggregate of 6,250,000 shares of the Registrant’s common stock issuable upon conversion of non-voting common stock.
|
| (3) |
The proposed maximum offering price per share has been estimated solely for the purpose of calculating the registration fee. The registration fee has been calculated in accordance with Rule 457(c) under the Securities Act based on the
average high and low prices reported for the Registrant’s common stock on December 5, 2025.
|